White label ELPA - ClinicalTrials.eu

Long-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis

Recruiting

3 1 1 1
Investigated diseases:
- Psoriasis
Investigated drugs:
- Deucravacitinib
- Ustekinumab
+6
A Study of Camizestrant Compared to Standard Hormone Therapy for Patients with ER-Positive HER2-Negative Early Breast Cancer After Initial Treatment

Recruiting

3 1 1 1
Investigated drugs:
+10
A study comparing odronextamab combined with chemotherapy versus rituximab combined with chemotherapy in adults with previously untreated follicular lymphoma

Recruiting

3 1 1 1
Investigated drugs:
+2
Comparing Two Doses of Dexamethasone to Improve Quality of Life in Patients 60 Years and Older Having Total Hip Replacement Surgery

Recruiting

3 1 1 1
Investigated diseases:
- Hip arthroplasty
Investigated drugs:
- Dexamethasone Sodium Phosphate
A Study Testing Brexpiprazole Given Once Weekly to Treat Sudden Worsening of Symptoms in Patients with Schizophrenia

Recruiting

3 1 1
Investigated diseases:
- Schizophrenia
Investigated drugs:
- Brexpiprazole
- Brexpiprazole Fumarate
A study of DT-7012 alone and in combination with pembrolizumab in patients with advanced solid tumors

Recruiting

2 1 1
Investigated diseases:
- Neoplasm malignant
A study testing the safety and effectiveness of inhaled hypochlorous acid in patients with chronic airway infections

Recruiting

1 1 1
Investigated diseases:
- Respiratory tract infection
Investigated drugs:
- HYPOCHLOROUS ACID
A Study of SPT-300 Compared to Placebo for Adults with Major Depressive Disorder with or without Anxious Distress

Recruiting

2 1

+1
A Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis

Recruiting

2 1
Investigated drugs:
- SPY002
+10
Testing delgocitinib cream for patients with vitiligo on the face

Recruiting

2 1 1 1
Investigated diseases:
- Vitiligo

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies